From ADCs to radiopharma: How AstraZeneca is trying to 'redefine oncology care'
AstraZeneca has been busy in recent years picking up a shopping list of assets and companies that have pumped up its oncology pipeline.

Apr 11, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 10, 2025 0
Apr 10, 2025 0
Apr 10, 2025 0
Apr 10, 2025 0
Apr 11, 2025 0
Apr 10, 2025 0
Apr 10, 2025 0
Apr 10, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Or register with email
Feb 9, 2025 0
Feb 10, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 13, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.